| Detailed information |
|---|
| CancerLivER ID | 2222 |
| Biomarker | DCP, (> =150 mAU/mL) |
| Biomarker Name/Symbol (given in Publication) | DCP (> =150 mAU/mL) |
| Biomolecule | Protein |
| Subject | Human |
| Degree of Validity | Biomarker for diagnosis of HCC and validated on independent dataset |
| Experimental Condition | Normal vs HCC, Cirrhosis |
| Cancer type | Hepatocellular carcinoma |
| Regulation | DCP upregulated in HCC |
| Level of significance | p < 0.001 |
| Source | Serum |
| PMID | 19852963 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | 1031 patients:39 HCC cases, 77 matched controls and 915 other non-HCC patients |
| Sensitivity | 43% |
| Specificity | 100% |
| Accuracy | NA |
| AUC | 0.82 |
| Disease | Human HCC |
| Year of Publication | 2010 |
| Clinical trial | YES |
| NCT No# (Clinical trial) | NCT01360255,NCT02272504,NCT03047603,NCT01361061 |